Accel Pharma Canada

Durhane Wong-Rieger is the President & CEO of the Canadian Organization for Rare Disorders (CORD). In her first…

Save Share

As the healthcare industry continues to hype about AI’s potential to be transformative, it is important to…

Save Share

As the President of Innovative Medicines Canada, Pamela Fralick leads the industry association for Canada’s…

Save Share

The research areas in which Canada has the potential to excel are numerous, one being the world of genomics. The…

Save Share

PharmaBoardroom’s list of personalities whose voices, opinions and decisions matter in Canadian pharma’s…

Save Share

Jan Hux is the President and CEO of Diabetes Canada. Canadians have been at the forefront of tackling diabetes…

Save Share

Brian Hilberdink, President of Novo Nordisk Canada, calls for collaboration between government and industry to…

Save Share

Mark Ware, the Chief Medical Officer of Canopy Growth Corporation, has intensely investigated the effects of…

Save Share

Canadian medical cannabis company Tilray’s stock surged by over 77 percent in the first three trading days of…

Save Share

As cannabis in Canada cruises towards legalization, Pharma giants race for patented products. “Big Pharma is…

Save Share

While many Canadian medical cannabis outfits cover the entire value chain, from research and development through to…

Save Share

As Canada’s emergent medical cannabis industry develops at home, several of the country’s leading companies are…

Save Share